Inhibition of DGAT1 in multiple glioblastoma cell lines and patient-derived GBM30 cells in vitro caused dysregulated lipid metabolism, triggering the accumulation of acylcarnitines and the production of ROS, resulting in apoptosis. The gene discussed is DGAT1; the disease is glioblastoma.